The next-generation protein sequencing platform of the future
For global impact.
For changing lives.
Understanding biology and disease better, faster, and more accurately.
Powered by semiconductor technology
Trillions of dollars in cumulative semiconductors investment drives our parallel sequencing, allowing rapid scale.
A product-agnostic platform for proteomics and beyond
Beyond color with Time Domain Sequencing™, end-to-end solution
Our proprietary technology powers massively-parallel sequencing, scaled at the speed of Moore’s Law. Our semiconductor chip functions like the chip on your smartphone, only it’s been designed to see biology without the limitations of color.
Proteomics platform power: changing the future of healthcare
90% of FDA approved drugs target a protein1
Almost all known diseases are linked to some dysfunction in protein signal transduction1, as humans share 99.9% of DNA.
1 The Human Proteome Tissue Atlas – Druggable Proteome, 2015, The Human Protein Atlas Project
85% of the human proteome is currently undrugged2
2 A Quest to Drug the Undruggable, June, Chemical & Engineering News, Volume 96, Issue 26, 2018
Over 100 million immunoassay tests performed a year3
3 “NPS Focus”, Rainbow makers, Royal Society of Chemistry (RSC), 2003, retrieved 29 December 2012
We have redefined industries, technologies, and expectations of transformative leadership.
We operate at the intersection of biochemistry, chemistry, hardware, molecular biology, photonics, semiconductor chips, and software.
Want to help transform healthcare?
If you are motivated by knowing the products you work on will change the lives of millions of people around the world, join us.